Chlorine in PDB 7qnw: The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs

The structure of The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs, PDB code: 7qnw was solved by D.Zhou, J.Ren, D.I.Stuart, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	114.29 / 2.40
Space group	P 32 2 1
Cell size a, b, c (Å), α, β, γ (°)	131.966, 131.966, 117.338, 90, 90, 120
R / Rfree (%)	20.6 / 24.7

The binding sites of Chlorine atom in the The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs (pdb code 7qnw). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs, PDB code: 7qnw:

Chlorine binding site 1 out of 1 in the The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of The Receptor Binding Domain of Sars-Cov-2 Omicron Variant Spike Glycoprotein in Complex with Beta-55 and EY6A Fabs within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl306 b:75.4 occ:1.00 N A:TRP49 2.9 48.5 1.0 O A:HOH403 3.1 54.2 1.0 CG2 B:THR98 3.3 59.6 1.0 CA A:GLU48 3.6 57.7 1.0 N B:THR98 3.6 61.3 1.0 CB A:TRP49 3.7 46.5 1.0 C A:GLU48 3.7 46.6 1.0 CG A:GLU48 3.8 62.0 1.0 CA A:TRP49 3.8 42.9 1.0 N B:TRP97 3.8 64.4 1.0 ND2 A:ASN62 3.8 57.0 1.0 O A:TRP49 3.9 47.7 1.0 CB B:THR98 4.2 49.5 1.0 CB A:GLU48 4.2 51.6 1.0 CA B:TRP97 4.3 70.8 1.0 C A:TRP49 4.3 51.2 1.0 O A:LEU47 4.4 51.2 1.0 CA B:THR98 4.5 57.3 1.0 C B:TRP97 4.5 61.8 1.0 C B:PRO96 4.6 72.8 1.0 CD2 B:PHE99 4.6 53.1 1.0 CA B:PRO96 4.7 69.0 1.0 N A:GLU48 4.7 45.3 1.0 O B:SER95 4.8 64.0 1.0 N B:PHE99 4.9 51.8 1.0 O A:GLU48 4.9 44.4 1.0 C A:LEU47 5.0 45.1 1.0

W.Dejnirattisai, J.Huo, D.Zhou, J.Zahradnik, P.Supasa, C.Liu, H.M.E.Duyvesteyn, H.M.Ginn, A.J.Mentzer, A.Tuekprakhon, R.Nutalai, B.Wang, A.Dijokaite, S.Khan, O.Avinoam, M.Bahar, D.Skelly, S.Adele, S.A.Johnson, A.Amini, T.G.Ritter, C.Mason, C.Dold, D.Pan, S.Assadi, A.Bellass, N.Omo-Dare, D.Koeckerling, A.Flaxman, D.Jenkin, P.K.Aley, M.Voysey, S.A.Costa Clemens, F.G.Naveca, V.Nascimento, F.Nascimento, C.Fernandes Da Costa, P.C.Resende, A.Pauvolid-Correa, M.M.Siqueira, V.Baillie, N.Serafin, G.Kwatra, K.Da Silva, S.A.Madhi, M.C.Nunes, T.Malik, P.J.M.Openshaw, J.K.Baillie, M.G.Semple, A.R.Townsend, K.A.Huang, T.K.Tan, M.W.Carroll, P.Klenerman, E.Barnes, S.J.Dunachie, B.Constantinides, H.Webster, D.Crook, A.J.Pollard, T.Lambe, N.G.Paterson, M.A.Williams, D.R.Hall, E.E.Fry, J.Mongkolsapaya, J.Ren, G.Schreiber, D.I.Stuart, G.R.Screaton. Sars-Cov-2 Omicron-B.1.1.529 Leads to Widespread Escape From Neutralizing Antibody Responses. Cell V. 185 467 2022.
ISSN: ISSN 1097-4172
PubMed: 35081335
DOI: 10.1016/J.CELL.2021.12.046